Method for treating inflammation
AssigneeThe Upjohn Company
InventorE. Myles Glenn
Life of this patent
Estimating the term…
Abstract
A method of treating inflammation comprising topical administration to mammals suffering from an inflammatory condition not associated with amicrobial component, employing selected antibiotics as the anti-inflammatory agent.
Claims13
A method of treating inflammation comprising administration to the epidermis or areas reached by rectal or vaginal suppositories to mammals suffering from an inflammatory condition not associated with a microbial component an effective dose for alleviating inflammation and its accompanying edema and erythema of an antibiotic selected from the group consisting of:
- Polyamido Streptomycin
- Streptomycin
- Penicillin-O
- Streptomycin-Dehydro
- Novobiocin
- Nystatin
- Lincomycin
- Streptolydigin
- Clindamycin
- and their pharmaceutically acceptable salts.
A method of treating inflammation comprising administration to the epidermis of mammals suffering from an inflammatory condition not associated with a microbial component an effective dose for alleviating inflammation and its accompanying edema and erythema of the antibiotic streptolydigin or a pharmaceutically acceptable salt thereof.
A method for treating inflammation comprising administration to the epidermis of mammals suffering from an inflammatory condition not associated with a microbial component an effective dose for alleviating inflammation and its accompanying edema and erythema of the antibiotic streptolydigin.
A method of treating inflammation comprising direct external application to the epidermis of mammals suffering from an inflammatory condition not associated with a microbial component an effective dose for alleviating inflammation and its accompanying edema and erythema of the antibiotic streptolydigin or a pharmaceutically acceptable salt thereof.
A method of treating inflammation comprising direct external application to the epidermis of mammals suffering from an inflammatory condition not associated with a microbial component an effective dose for alleviating inflammation and its accompanying edema and erythema of an antibiotic selected from the group consisting of:
- Polyamido Streptomycin
- Streptomycin
- Pencillin-O
- Streptomycin-Dehydro
- Novobiocin
- Nystatin
- Lincomycin
- Streptolydigin
- Clindamycin
- and their pharmaceutically acceptable salts.
Dependencies are inferred from the claim text.